Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 1 of 1 for:    GEN-PEAK | Huntington Disease
Previous Study | Return to List | Next Study

A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04000594
Recruitment Status : Completed
First Posted : June 27, 2019
Last Update Posted : May 31, 2022
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 18, 2022
Actual Study Completion Date : January 18, 2022